Current and experimental therapeutic options for cytomegalovirus disease.

Subjects

Subjects :

Administration, Oral
Antiviral Agents administration & dosage
Antiviral Agents adverse effects
Antiviral Agents pharmacokinetics
Cidofovir
Cytomegalovirus Retinitis drug therapy
Cytosine analogs & derivatives
Cytosine pharmacokinetics
Cytosine pharmacology
Cytosine therapeutic use
Delayed-Action Preparations therapeutic use
Foscarnet adverse effects
Foscarnet pharmacokinetics
Foscarnet therapeutic use
Ganciclovir administration & dosage
Ganciclovir adverse effects
Ganciclovir pharmacokinetics
Ganciclovir therapeutic use
Guanine analogs & derivatives
Guanine pharmacokinetics
Guanine pharmacology
Humans
Injections, Intravenous
Organophosphorus Compounds pharmacokinetics
Organophosphorus Compounds pharmacology
Organophosphorus Compounds therapeutic use
Antiviral Agents therapeutic use
Cytomegalovirus
Cytomegalovirus Infections drug therapy
Organophosphonates

Details

Language :

English

ISSN :

1079-2082

Volume :

53

Issue :

8 Suppl 2

Database :

MEDLINE

Journal :

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Publication Type :

Academic Journal

Accession number :

8728375

Full Text :

https://doi.org/10.1093/ajhp/53.8_Suppl_2.S4